A specialty pharmaceutical company focused on the development and commercialization of difficult to make products.
About Us
Partnerships
Our aim is to be a partner that you can trust and foster relationships where the whole is greater than the sum of its parts.
Products
We focus on developing difficult generic and 505(b)(2) products. Through our strong domestic and global partnerships, products will include both patented and off-patented brands and generics.
Markets
We target products to the retail, institutional and specialty pharmaceutical markets. Prioritizing patient access is one of our key Company Values.
Our Pipeline
Epilepsy
Oral Solid
Launch: Q2 2022
Hypertension
Injection
Launch: Q3 2023
Acidosis
Injection
Launch: Q4 2022
Epilepsy
Oral Solid
Launch: Q2 2022
Hypertension
Injection
Launch: Q3 2023
Acidosis
Injection
Launch: Q4 2022
Contact Us
We’re happy to share more about the scope of our products, team, markets and answer questions. Reach out and we’ll schedule a time to connect.
We look forward to connecting.